All entries for: Denali Therapeutics Inc.

May 7, 2026

Denali Therapeutics Inc.

Neutral Outlook

South San Francisco, CA
501-1,000 employees

While we do not believe that the IRA or its effects will impact our ability to obtain patents in the near future, we cannot be certain whether it will affect our patent strategy in the long run.

Disease Area: Neurological Diseases, Rare Diseases
Drug Type: Biologic, Small Molecule
Scroll to Top